课题基金 / 基金详情

Structure and function of penicillin-binding protein from methicillinresistans Staphylococcus aureus

Structure and function of penicillin-binding protein from methicillinresistans Staphylococcus aureus
耐甲氧西林金黄色葡萄球菌青霉素结合蛋白的结构和功能
批准号:
06454074
负责人:
MATSUZAWA Hiroshi
金额:
$4.74万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

MATSUZAWA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
为了通过晶体结构了解其结构-功能关系,我们尝试对耐甲氧西林金黄色葡萄球菌青霉素结合蛋白(MRSA-PBP)进行纯化和结晶。为了使原本是膜结合的MRSA-PBP具有水溶性,将其n端疏水段截断。我们构建了截断的MRSA-PBP融合蛋白,该融合蛋白与His-tag的c端和麦芽糖结合蛋白(MBP)结合。His-tag融合蛋白产量不高,且融合蛋白不稳定,无法纯化。纯化了MBP融合蛋白。经过蛋白酶处理后,从融合蛋白中去除MBP结构域。截断的MRSA-PBP也不稳定,失去了青霉素结合活性,因此我们不得不放弃MRSA-PBP的结晶。与MRSA-PBP一样,广谱β -内酰胺酶也引起了人们的广泛关注。近年来,人们发现肺炎克雷伯菌、氧化克雷伯菌和大肠杆菌等肠杆菌科细菌通过产生广谱β -内酰胺酶获得对广谱头孢类抗生素的耐药性。从大肠杆菌中获得的Toho-1 β -内酰胺酶是一种扩展谱酶,其氨基酸序列与TEM-1 β -内酰胺酶(a类酶)的同源性约为60%。通过对氨基酸序列的比较,我们推测,从常见的A类β -内酰胺酶中替换氨基酸的突变,即Arg244替换Thr和Glu274- (Arg275) - asn276替换Arg- (Arg) -Arg,对于Toho-1酶获得底物特异性的扩展是重要的。通过位点定向诱变构建的突变酶分析表明,Arg274和Arg276对其扩展的底物特异性都是必需的,并且位置244的Thr而不是Arg对这两个精氨酸残基的功能都很重要。
英文摘要
In order to understand the structure-function relationship through the crystal sturcture, we tried to purify and then aimed to crystallize methicillin-resistant Staphylococcus aureus penicillin-binding protein (MRSA-PBP). To make water-soluble MRSA-PBP which is membrane-bound originally, its N-terminal hydrophobic segment was truncated. We constructed fusion proteins of the truncated MRSA-PBP which was fued with the C-terminal side of His-tag and maltose-binding protein (MBP). The production of the His-tag fusion protein was not so much, and furthermore the fusion protein was unstable and unable to be purified. The MBP fusion protein was purified. After protease treatment ot remove MBP domain from the fusion protein. the truncated MRSA-PBP was also unstable and lost the penicillin-bindin activity, Thus, we had to give up the crystallization of MRSA-PBP.As well as MRSA-PBP,extended-spectrum beta-lactamases have attracted public attention. Recently, it was found that Enterobacteriaceae such as Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli acquire resistance aganist expanded-spectrum cephem antibiotics by producing the extended-spectrum beta-lactamases. Toho-1 beta-lactamase obtained from E.coli is one of the extended-spectrum enzymes, and its amino acid sequence homology with TEM-1 beta-lactamase (a class A enzyme) is about 60%. By comparing the amino acid sequences, it was presumed that mutations of amino acid replacements from usual class A beta-lactamases, Arg244 with Thr and Glu274- (Arg275) -Asn276 with Arg- (Arg) -Arg, were important for the Toho-1 enzyme to acquire the extension of the substrate specificity. Analyzes of mutant enzymesconstructed by site-directed mutagenesis suggested that both Arg274 and Arg276 were essential for its extended substrate specificity, and that Thr, instead of Arg, at position 244 was important for functioning of the both arginine residues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
On a study of a solution with a transition layer for a bistable reaction diffusion equation with a heterogeneous environment
  • 批准号:
    20740098
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $1.16万
  • 财政年份:
    2008
  • 负责人:
    MATSUZAWA Hiroshi
  • 依托单位:
Analyses of the crystal structure of 4-α-glucanotransferase and its production mechanism of new cycloamylose
  • 批准号:
    12460047
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.15万
  • 财政年份:
    2000
  • 负责人:
    MATSUZAWA Hiroshi
  • 依托单位:
Studies on a hyperthermostable 4-α-glucanotransferase: X-ray structure analysis and enzymatic reaction mechanism
Analyzes of the mechanisms of thermophilic and alkalophilic properties of aqualysin I,a protease from an extreme thermophile
  • 批准号:
    08456046
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $0.7万
  • 财政年份:
    1996
  • 负责人:
    MATSUZAWA Hiroshi
  • 依托单位:
国内基金
海外基金
去铁胺修饰Fe3+-鞣花酸纳米酶敷料靶向杀灭MRSA促进糖尿病伤口愈合机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢颖
  • 依托单位:
野菊花内生真菌中抗MRSA活性成分及其作用机制
  • 批准号:
    JCZRLH202601040
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
小分子化合物T-2307及其类似物通过PG-PMF-ATP通路抗MRSA感染的分子机制及应用研究
靶向新航向:STAT3抑制剂对MRSA的抗菌作用及其分子机制研究
  • 批准号:
    2026JJ50552
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    吴苑
  • 依托单位: